{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:54:05Z","timestamp":1793843645998,"version":"4.6.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115433","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:21:37Z","timestamp":1774038097000},"page":"115433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing"],"prefix":"10.1016","volume":"29","author":[{"given":"Breanna","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Roenicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton M.","family":"Roeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Patamawenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya van\u2019t","family":"Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Koory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulley","family":"Shofner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellison","family":"Ober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceanna","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalamar","family":"Georgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Readler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Vostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Ziff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Maule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Callier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Kovacikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett C.","family":"Souter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Douek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-8705","authenticated-orcid":false,"given":"Mark","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115433_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJMc2302462","article-title":"Durability of Bivalent Boosters against Omicron Subvariants","volume":"388","author":"Lin","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115433_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.115433_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115433_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib6","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1038\/s41467-023-43842-7","article-title":"Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine","volume":"14","author":"Thwaites","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib7","article-title":"Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals","volume":"11","author":"Butler","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8051","article-title":"Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination","volume":"7","author":"Gorochov","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.115433_bib9","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib10","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1016\/j.cell.2022.11.006","article-title":"Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys","volume":"185","author":"Le Nou\u00ebn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115433_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115433_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Le\u00f3n","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","article-title":"Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques","volume":"626","author":"McMahan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115433_bib14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115433_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","article-title":"Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates","volume":"25","author":"Gagne","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115433_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","article-title":"Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report","volume":"8","author":"Knisely","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/jama.2023.0644","article-title":"Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines","volume":"331","author":"Rubin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2026.115433_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115433_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180784","article-title":"An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA","volume":"9","author":"Sun","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.115433_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin((R)))","volume":"8","author":"Singh","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1473-3099(23)00350-X","article-title":"Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial","volume":"23","author":"Li","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115433_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jiad338","volume":"229","author":"Wang","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115433_bib24","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-025-62698-7","article-title":"Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.115433_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2666-5247(24)00025-9","article-title":"Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study","volume":"5","author":"Jackson","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2026.115433_bib27","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2013.04.035","article-title":"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits","volume":"31","author":"Kuschner","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.115433_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140794","article-title":"A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity","volume":"131","author":"Matsuda","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115433_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau2710","article-title":"Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine","volume":"4","author":"Matsuda","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/CVI.00475-15","article-title":"Persistence of Antibody to Influenza A\/H5N1 Vaccine Virus: Impact of AS03 Adjuvant","volume":"23","author":"Chen","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.isci.2026.115433_bib31","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/JVI.02864-12","article-title":"Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates","volume":"87","author":"Richardson","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115433_bib32","doi-asserted-by":"crossref","first-page":"S1032","DOI":"10.1093\/infdis\/jir332","article-title":"Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs","volume":"204","author":"Richardson","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115433_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115433_bib34","article-title":"Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response","volume":"8","author":"Collins","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2026.115433_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.115433_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01487691","article-title":"A new hamster model for adenoviral vaccination","volume":"100","author":"Hjorth","year":"1988","journal-title":"Arch. Virol."},{"key":"10.1016\/j.isci.2026.115433_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biology10121253","article-title":"Animal Models in Human Adenovirus Research","volume":"10","author":"Bertzbach","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.isci.2026.115433_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/196244a0","article-title":"Fatal Infection of New-Born Hamsters by an Adenovirus of Human Origin","volume":"196","author":"Pereira","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115433_bib39","first-page":"197","article-title":"Studies of the Adenoidal-Pharyngeal-Conjunctival (Apc) Group of Viruses","volume":"61","author":"Rowe","year":"1955","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.isci.2026.115433_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-021-00301-y","article-title":"Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease","volume":"6","author":"van der Lubbe","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib41","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.vaccine.2023.09.021","article-title":"Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine","volume":"41","author":"Lassauni\u00e8re","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.115433_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41392-022-01065-0","article-title":"Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115433_bib43","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1038\/s41467-023-40033-2","article-title":"Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters","volume":"14","author":"Machado","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.medj.2022.03.009","article-title":"mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2","volume":"3","author":"Darling","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.isci.2026.115433_bib45","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1038\/s41467-022-32248-6","article-title":"ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants","volume":"13","author":"van Doremalen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib46","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.115433_bib47","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115433_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115433_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.isci.2026.115433_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104402","article-title":"SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination","volume":"87","author":"Liew","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115433_bib51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41467-025-55938-3","article-title":"Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology","volume":"16","author":"Wickenhagen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib52","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/s41467-021-25156-8","article-title":"SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters","volume":"12","author":"Port","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib53","article-title":"Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates","author":"Moliva","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.115433_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115433_bib55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/14760584.2023.2242528","article-title":"A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov","volume":"22","author":"Wang","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib56","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41591-022-01780-9","article-title":"Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults","volume":"28","author":"Killingley","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115433_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/hematolrep14040050","article-title":"COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes","volume":"14","author":"Allas","year":"2022","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.isci.2026.115433_bib58","doi-asserted-by":"crossref","first-page":"114329","DOI":"10.1016\/j.isci.2025.114329","article-title":"Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4","volume":"29","author":"Sallard","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.115433_bib59","article-title":"Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants","volume":"99","author":"Beavis","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115433_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.2469","article-title":"1938. CoviLiv\u2122, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001","volume":"10","author":"Kaufmann","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.isci.2026.115433_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Leon","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2026.115433_bib62","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1038\/s41467-025-60481-2","article-title":"Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response","volume":"16","author":"Matsuda","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115433_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115433_bib64","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115433_bib65","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115433_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031177","article-title":"Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin","volume":"7","author":"Alexander","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115433_bib67","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115433_bib68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115433_bib69","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1016\/j.vaccine.2005.04.023","article-title":"Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency","volume":"23","author":"Wang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.115433_bib70","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115433_bib71","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109744118","article-title":"A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115433_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chom.2021.03.002","article-title":"SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines","volume":"29","author":"Shen","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.115433_bib73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115433_bib74","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"Anthony","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.115433_bib75","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.cell.2022.03.038","article-title":"mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron","volume":"185","author":"Gagne","year":"2022","journal-title":"Cell"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226008084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226008084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:34:36Z","timestamp":1790692476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226008084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226008084"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115433","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115433"}}